Navigation Links
Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008
Date:3/5/2009

(expenses): Foreign exchange gain (loss) (1,032) 1,032 h - Investment and other income (498) 544 i 46 Interest expense on long-term debt (10,639) 559 j (10,080) Write-down and other deferred financing charges (3,000) 3,000 k - Write-down / loss on redemption of investments (10,964) 10,964 l - Write-down of assets held for sale (1,283) 1,283 m - Write-down of goodwill (50,285) 50,285 n - ------------------------------------------------------------------------- ------------------------------------------------------------------------- (77,701) 67,667 (10,034) ------------------------------------------------------------------------- ------------------------------------------------------------------------- (Loss) income from continuing operations before income taxes (79,540) 77,971 (1,569) Income tax (recovery) expense (2,577) 3,629 o 1,052 ------------------------------------------------------------------------- ------------------------------------------------------------------------- (Loss) income from continuing operations (76,963) 74,342 (2,621) Net loss from discontinued operations, net of income taxes - - - ------------------------------------------------------------------------- Net (loss) income for the period $ (76,963) $ 74,342 $ (2,621) ------------------------------------------------------------------------- Basic and diluted net loss per common share from continuing operations $ (0.90) $ (0.03)
'/>"/>
SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Related biology technology :

1. Angiotech Pharmaceuticals, Inc. announces new Senior Secured Term Loan and Credit Facilities
2. Angiotech Pharmaceuticals announces time change of conference call and webcast
3. Angiotech announces termination of note purchase agreement with Ares Management and New Leaf Venture Partners
4. Angiotech Announces Webcast and Call-in Numbers for Annual and Special General Meeting of Shareholders
5. Angiotech Announces Extension of the Expiration Date of its Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014
6. Angiotech receives CE Mark approval of HemoStream(TM) Chronic Dialysis Catheter
7. Angiotech wins before the UK House of Lords
8. Angiotech to Establish Separate Operating and Royalty Businesses
9. Angiotech To Commence Cash Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014
10. Angiotech announces market launch of Quill(TM) SRS MONODERM(TM)
11. Angiotechs corporate partner, Cook Medical, announces positive interim results for its Zilver(R) PTX(TM) clinical study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... N.C. , Aug. 20, 2014 ... research services located in Raleigh, NC ... Bradford Evans as Vice President of Administration. ... Brad will oversee all corporate processes, including their ... joining Clintrax Global, Brad worked as an HR ...
(Date:8/20/2014)... , Aug. 20, 2014 Neurotrope, Inc. ... a conference call to provide an update on ... Eastern daylight timeDial-in numbers:(888) 505-4369 (U.S. and Canada) ... web cast: www.neurotropebioscience.com , under "Investor Relations"The teleconference ... completion through September 2, 2014 at (888) 203-1112 ...
(Date:8/20/2014)... CA (PRWEB) August 20, 2014 The ... is being held on October 29-30 in San ... from industry, academic and government researchers and clinicians focused ... the space. , In the twelve years since ... hundred therapies have been introduced with pharmacogenetic information in ...
(Date:8/20/2014)... Cranford, NJ (PRWEB) August 20, 2014 ... solutions, announced today that it has expanded its myPROpad™ ... of the EQ-5D-5L, one of the most widely ... for measuring general health status. The EQ-5D is used ... to generate a measure that can be used to ...
Breaking Biology Technology:Clintrax Global, Inc. Announces Addition to Executive Team 2Neurotrope To Host Conference Call 26th Annual Personalized and Precision Medicine Conference Bringing Together Thought Leaders to Discuss Clinical Implementation, Dx Reimbursement, Big Data, and Sequencing 2EQ-5D™ Assessment Now Available for iPad 2
... (NASDAQ: QCOR ) announced today that executive management ... be held on February 15-16, 2012 in New York.  Steve ... to present an overview of the Company on Thursday, February ... live webcast and subsequent archived replay of the presentation will ...
... a leading global provider of distributed and specialty ... in the "Drive for Innovation" tour, sponsored by ... "pit stop" during the tour,s recent swing through ... role in powering innovation by companies driving technological ...
... in the light like the scales on a butterfly,s ... a revolutionary new approach to point-of-care medical diagnostics, according ... Design Engineering . Thomas Schalkhammer and colleagues at ... Palkovits of the University of Applied Sciences, in Wiener ...
Cached Biology Technology:Questcor Pharmaceuticals to Present at the Leerink Swann Global Healthcare Conference on February 16, 2012 2Micross Components Hosts Stop on "Drive for Innovation" Tour 2The butterfly effect in nanotech medical diagnostics 2
(Date:8/19/2014)... is available in German . ... intermittent energy sources. If a large amount of electricity is ... excess energy will have to be stored during productive periods ... storage capacities are far from adequate for the purpose. Science ... important focus lies on battery systems that used to be ...
(Date:8/19/2014)... not a monkey. It,s not a lemur. It,s not an ... Philippine tarsier: a tiny, adorable and downright "cool" primate from ... Americans are familiar with," said Rafe Brown, curator-in-charge at the ... and ears; an extremely cute, furry body; a long tail ... fingers and toe tips that look a bit like the ...
(Date:8/19/2014)... measurements from fish purchased at retail seafood counters ... which mislabeling can expose consumers to unexpectedly high ... stock "substitutions"which falsely present a fish of the ... the most dangerous mislabeling offense, according to new ... , "Accurate labeling of seafood is essential to ...
Breaking Biology News(10 mins):Asian inventions dominate energy storage systems 2Asian inventions dominate energy storage systems 3Philippine tarsier gets boost from Kansas research, and genetic proof of a new variety 2Philippine tarsier gets boost from Kansas research, and genetic proof of a new variety 3Seafood substitutions can expose consumers to unexpectedly high mercury 2Seafood substitutions can expose consumers to unexpectedly high mercury 3
... lives at extremely high temperatures could help understand structures ... Biology Laboratory (EMBL) and Heidelberg University, both in Heidelberg, ... genome of a heat-loving fungus, and used that information ... inner ring of the nuclear pore. The study was ...
... The development of a new cell-culture system that ... become coated with protective myelin opens up new avenues ... myelin regulates a key protein involved in sending long-distance ... characterized by damage to the myelin sheath surrounding nerve ...
... Exonhit (Alternext: ALEHT), a biotech company focused on ... are pleased to announce the successful completion of a ... to an additional strategic preclinical animal model species. ... gene deregulation and the expanding interest in developing biomarkers ...
Cached Biology News:A hot species for cool structures 2MS research: Myelin influences how brain cells send signals 2MS research: Myelin influences how brain cells send signals 3MS research: Myelin influences how brain cells send signals 4
assays for phosphatase, lipase, nucleoside triphosphatases (ATPase, GTPase etc). HTS and follow up studies for phosphatase inhibitors. Quantitation of phosphate content in protein, lipids, and DNA....
... with Purpose -- The Varian ... the highest level of flexibility ... an affordable, easy-to-use system. The ... workstation guarantees success with today's ...
Homo sapiens 4-aminobutyrate aminotransferase Antigen: Recombinant Protein...
Human DCIR/CLEC4A Phycoerythrin MAb (Clone 216110)...
Biology Products: